Material Type

• Blood (whole) (1)
• Buffy coat (1)
• Cerebrospinal fluid (1)
• Dried whole blood (2)
• Plasma (double spun) (1)
• Plasma (single spun) (2)
• Saliva (1)
• Serum (2)
• Urine (first morning) (1)
• Urine (random) (2)

Microscopic Assessment

• Affected (2)
• Non-affected (1)
• Not applicable (4)

Storage Temperature

• -35°C to -18°C (3)
• -85°C to -60°C (4)

Associated Data

• Biomarker datasets (1)
• Clinical records (4)
• Followup records (2)
• Freezer temperature logs (2)
• Genomic datasets (1)
• Microbiological results (2)
• Participant Ethnicity (2)
• Pre-analytical data (1)
• Quality indicators (1)
• Survey data (3)
• Treatment records (3)

Timeframe

• Immediate (3)
• 0 - 3 months (4)
• 3 - 6 months (2)
• > 6 months (1)

Participant Count

• 1 - 10 (1)
• 11 - 100 (5)
• 101 - 500 (2)
• 1001 - 3000 (1)

Sex

• Both sexes (6)

Age Range

• Young child (2 - 6 years) (1)
• Child (6 - 12 years) (3)
• Adolescent (12 - 18 years) (3)
• Young adult (18 - 40 years) (5)
• Adult (> 40 years) (4)

Collection Type

• Case-control (2)
• Clinical Trial (1)
• Cross-sectional (1)
• Disease specific (4)

Consent Restriction

• No Commercial restriction (4)
• No Disease area restriction (6)
• No Genetic analysis restriction (2)
• No Human genetic analysis restriction (4)
• No restrictions (1)
• No Project specific restriction (5)
• No Scope of use restriction (6)

Collection Status

• Completed (6)

Access Condition

• Open to applicants (4)
• Open only through collaboration (3)

Country

• Belgium (1)
• France (1)
• Ghana (1)
• Kenya (2)
• Switzerland (1)

County